Form 4 for ANIK Anika Therapeutics, Inc.
Accepted 2021-08-12 00:00:00 ET · period of report 2021-08-10 · accession 0001171843-21-005897 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-12 | 2021-08-10 | ANIK | Levitz Michael L | EVP, CFO, Treas | M - OptEx | $0.00 | +3,859 | 3,859 | New | $0 |
| D | 2021-08-12 | 2021-08-10 | ANIK | Levitz Michael L | EVP, CFO, Treas | M - OptEx | $0.00 | -3,859 | 7,718 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-10 | M | A | 3,859 | $0.00 | 3,859 | D | — | — | (F1) Reflects the first vesting installment of RSUs granted on August 10, 2020. The 3,859 shares resulting from the RSU vest were retained in full as a result of Mr. Levitz's election to pay cash to cover the applicable taxes resulting from the RSU vest. |
| 2 | Derivative | Restricted Stock Unit | 2021-08-10 | M | D | 3,859 | $0.00 | 7,718 | D | $0.00 · — to — | 3,859 Common Stock | (F2) Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning August 10, 2021. |